Antonio J García Ruiz, Nuria García-Agua Soler, Enrique Herrera Acosta, Iris Zalaudek, & Josep Malvehy. (2022). Benefit-risk assessment of sonidegib and vismodegib in the treatment of locally advanced basal cell carcinoma. BioExcel Publishing Ltd.
Chicago Style (17th ed.) CitationAntonio J García Ruiz, Nuria García-Agua Soler, Enrique Herrera Acosta, Iris Zalaudek, and Josep Malvehy. Benefit-risk Assessment of Sonidegib and Vismodegib in the Treatment of Locally Advanced Basal Cell Carcinoma. BioExcel Publishing Ltd, 2022.
MLA (9th ed.) CitationAntonio J García Ruiz, et al. Benefit-risk Assessment of Sonidegib and Vismodegib in the Treatment of Locally Advanced Basal Cell Carcinoma. BioExcel Publishing Ltd, 2022.
Warning: These citations may not always be 100% accurate.